Evidence Hub

A novel SPI1 variant (c.566T > C (p.Ile189Thr)) possibly associated with autosomal dominant agammaglobulinemia in a Chinese girl

Wu P, Zhao J, Yu Z, Li H, Liu Z, Peng Y, Cai Z, Chen D et al.

BMC pediatrics, 2026

Abstract

Background: Agammaglobulinemia is a rare primary immunodeficiency disorder characterized by deficient B lymphocyte development and reduced serum immunoglobulin levels, leading to recurrent infections. Autosomal dominant agammaglobulinemia (AD-AGM) related to SPI1 gene mutations is extremely rare, with limited reported cases worldwide.

Case presentation: A 13-year-old Chinese girl was admitted with recurrent respiratory infections for over 6 years and acute cough/fever lasting 1 week. Laboratory tests showed significantly decreased IgG (3.94 g/L) and IgA (0 g/L) levels, with a B lymphocyte ratio (CD3-CD19+)/ lymphocytes) of 0.03% and absolute B cell count of 1 cell/µL. Whole-exome sequencing identified a heterozygous SPI1 variant (c.566T > C (p.Ile189Thr)) inherited from her asymptomatic mother; her father and younger brother did not carry the variant. The variant is annotated as "of uncertain significance (VUS)" according to ACMG criteria, supporting a potential diagnosis of AD-AGM associated with the SPI1 variant. Literature review indicated that the c.566T > C mutation in the SPI1 gene had not been previously reported. Additionally, we summarized the clinical and genetic characteristics of patients from different continents. The patient received anti-infection therapy, intravenous gamma globulin infusion, bronchoalveolar lavage, and symptomatic treatment (e.g., antipyretic, antitussive, expectorant, and nutritional support), with significant clinical improvement. Long-term…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free